Cargando…

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses

Background: Tripartite motif containing 46 was initially identified as the oncogene in several human tumors. However, the clinical value and potential functions of tripartite motif containing 46 (TRIM46) in clear cell renal cell carcinoma (ccRCC) remained largely unclear. Methods: The expressing pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiang-bin, Zhao, Jing, Liang, Xue-feng, Guo, Xu-dong, Jiang, Shao-bo, Xiang, Yu-zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645697/ https://www.ncbi.nlm.nih.gov/pubmed/34881275 http://dx.doi.org/10.3389/fmed.2021.785331

Ejemplares similares

Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2021)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
por: Xiang, Zhenfei, et al.
Publicado: (2021)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma
por: Liu, Zhi-Guo, et al.
Publicado: (2022)

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma
por: Wang, Jinxing, et al.
Publicado: (2018)

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
por: Peng, Longfei, et al.
Publicado: (2022)

Identification of Potential Diagnostic Biomarkers From Circulating Cells During the Course of Sleep Deprivation-Related Myocardial Infarction Based on Bioinformatics Analyses
por: Chen, Xiang, et al.
Publicado: (2022)

Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
por: Meng, Zhuo, et al.
Publicado: (2023)

Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Huang, Hao, et al.
Publicado: (2021)

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020)

Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Zhang, Xu-Zhe, et al.
Publicado: (2021)

Comprehensive analysis of expression profiles and prognosis of TRIM genes in human kidney clear cell carcinoma
por: Shen, Junwen, et al.
Publicado: (2022)

Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma
por: Huang, Jingyi, et al.
Publicado: (2020)

Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model
por: Liu, Bin, et al.
Publicado: (2020)

Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma
por: Zhang, Zan, et al.
Publicado: (2021)

Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma
por: Wang, Ganggang, et al.
Publicado: (2022)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
por: Ha, Mihyang, et al.
Publicado: (2019)

P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study
por: Chu, Jie, et al.
Publicado: (2023)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

TRIM29 in Cutaneous Squamous Cell Carcinoma
por: Hsu, Che-Yuan, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining
por: Xu, Zekun, et al.
Publicado: (2023)

Integrating bioinformatic analysis and detailed experiments reveal an EMT‐related biomarker for clear cell renal cell carcinoma
por: Ge, Yue, et al.
Publicado: (2023)

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib
por: Zheng, Wan-Xiang, et al.
Publicado: (2015)

Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets
por: Naghdibadi, Mohammadjavad, et al.
Publicado: (2023)

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019)

DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
por: Lee, Man-Gang, et al.
Publicado: (2022)

Bioinformatic and experimental analyses of key biomarkers in pancreatic cancer
por: Ren, Tianyu, et al.
Publicado: (2021)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols
por: Budai, Bettina Katalin, et al.
Publicado: (2022)

Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram
por: Cheng, Delu, et al.
Publicado: (2023)

COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA
Publicado: (2013)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020)

Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma
por: Somsuan, Keerakarn, et al.
Publicado: (2023)

Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses
por: Zhang, Wei, et al.
Publicado: (2020)

A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes
por: Qiu, Qiangmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tl1o4qc8coh1ns6kubi8j12qc